findmyKOL

Anand Vaidya, MD

Enriched profile

Chief, Division of Endocrinology, Diabetes, and Metabolism, Mass General Brigham; Director, Center for Adrenal Disorders, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School · Brigham and Women's Hospital

ORCIDNPI
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyEndocrinology, Diabetes & MetabolismFocusHormonal Regulation and Hypertension+4
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2010–2026

Anand Vaidya is Chief, Division of Endocrinology, Diabetes, and Metabolism, Mass General Brigham; Director, Center for Adrenal Disorders, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School at Brigham and Women's Hospital. OpenAlex indexes 328 publications with 10,440 citations (h-index 57); ClinicalTrials.gov lists 7 registered studies with this person as an investigator.

Data verified 24 Aug 2026

Overview

Updated 27 Aug 2026

Anand Vaidya, MD, MMSC, is Chief, Division of Endocrinology, Diabetes, and Metabolism, Mass General Brigham at Brigham and Women's Hospital / Harvard Medical School (Mass General Brigham). The public record shows 328 publications with 10,440 citations (h-index 57), centered on Hormonal Regulation and Hypertension, Adrenal and Paraganglionic Tumors, Adrenal Hormones and Disorders. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 6 companies, 7 NIH-funded awards (2010–2026).

  • Most recent indexed publication: 2026 · Nature reviews. Disease primers
  • Top research focus: Hormonal Regulation and Hypertension
  • 7 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 6 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Obesity3 trialsHypertension2 trialsHyperparathyroidism2 trialsVitamin D Deficiency1 trialType 2 Diabetes1 trialHyperparathyroidism, Primary1 trialHyperaldosteronism1 trialHyperplasia1 trialOverweight1 trialMetabolic Syndrome1 trialCushing's Syndrome

Research focus

OpenAlex concept fingerprint
Hormonal Regulation and HypertensionAdrenal and Paraganglionic TumorsAdrenal Hormones and DisordersRenin-Angiotensin System StudiesSodium Intake and Health

Drugs & molecules

across trials, industry payments and publications
Lysodrengeneric · MitotaneClinical trialsIndustry payments1Publications1Korlymgeneric · MifepristoneClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Brigham and Women's HospitalClinical trials7Industry paymentsAstraZeneca UK LimitedClinical trialsIndustry payments6AstraZeneca Pharmaceuticals LPClinical trialsIndustry payments2

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
328publications

Distinct works indexed by OpenAlex, matched via ORCID; 58 in PubMed.

10,440citations

Total citations across indexed works.

57h-index

Hirsch index (OpenAlex). i10-index 138.

Clinical & industry

trials, payments and federal funding
7clinical trials

Investigator role on registered studies.

View trials
6companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
7NIH grants · 2010–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Hormonal (systemic)

    35.4%
    Mineralocorticoids21.9%
    Fludrocortisone Acetate100%
    Part D16 patients
    l-Thyroxine13.5%
    Levothyroxine Sodium100%
    Part D<11 patients
  • Sensory organs

    26.5%
    Corticosteroid26.5%
    Hydrocortisone100%
    Part D18 patients
  • Cardiovascular

    23.5%
    Aldosterone antagonist (MRA)17.3%
    Eplerenone51%Spironolactone49%
    Part D<11 patients
    Calcium channel blocker6.2%
    Amlodipine Besylate100%
    Part D<11 patients
1 more therapeutic area behind the reveal.Reveal →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

7 NIH research awards on record, funded 20102026 per NIH RePORTER. The latest:

Congress activity

Updated 27 Aug 2026

33 congress contributions (2019–2025) across AACE, ASCO, ENDO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/anand-vaidya-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • Google Scholar

    scholar.google.com/citations

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholar.google.com

Mentions by others

where others cite or feature them
  • Other

    primaryaldosteronism.org/physician/anand-vaidya-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →primaryaldosteronism.org
  • Other

    backtable.com/shows/curbsiders/contributors/dr-anand-vaidya

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →backtable.com
  • Other

    endocrine.org/our-community/profiles/vaidya-anand

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrine.org
1 more mention behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Director

    Center for Adrenal Disorders, Brigham and Women's Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaidya.bwh.harvard.edu
  • Chief

    Division of Endocrinology, Diabetes, and Metabolism, Mass General Brigham

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.massgeneralbrigham.org
  • Principal Investigator

    The Vaidya Lab, Brigham and Women's Hospital / Harvard Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vaidya.bwh.harvard.edu
2 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances
  • Guest

    The Curbsiders Internal Medicine podcast, Episode #515 "Primary Aldosteronism, A Deep Dive: Easy on the Salt!"

    2026
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →backtable.com
  • Presenter

    "Primary Aldosteronism: Once a Zebra, Now a Horse," Endocrinology Grand Rounds, George Washington University School of Medicine

    2024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cme.smhs.gwu.edu

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.